文献速递免疫规划传染病防控与疫情报告

理解新冠疫情期间非药物干预导致的B群侵袭性脑膜炎球菌病免疫缺口

Understanding the immunity gap for serogroup B invasive meningococcal disease due to non-pharmaceutical interventions during the Covid-19 pandemic.
PubMed 文献 · Vaccine · 2025-08-23

该研究通过血清流行病学调查,检测2019、2020和2021年采集的25岁以下人群血清中B群脑膜炎球菌杀菌抗体滴度,发现2019至2021年间所有年龄段抗体阳性率显著下降,而6至24月龄婴儿的抗体几何平均滴度显著高于2001至2004年。结论认为新冠疫情期间非药物干预导致抗体水平显著下降,疫苗覆盖率未受显著影响。

要点

  • 2019至2021年间所有年龄段人群B群脑膜炎球菌杀菌抗体阳性滴度(≥4)比例显著下降。
  • 6至24月龄婴儿2019、2020和2021年SBA GMT显著高于2001至2004年。
  • 2020至2021流行病年疫苗覆盖率未受显著影响。

核心结论

  • 新冠疫情期间非药物干预导致抗体水平显著下降,最可能原因是鼻咽部无症状携带脑膜炎球菌的暴露减少。
  • 常规免疫规划中断不太可能是抗体下降的 contributing 因素,因为2020至2021流行病年疫苗覆盖率未受显著影响。

研究设计与样本

  • 血清流行病学研究,样本来自英国健康安全局(UKHSA)血清流行病学单元(SEU),按年龄分层。
  • 请求1656份样本,获得1586份可用样本,最终获得1371份有效滴度。
  • 使用标准化验证的SBA试验检测针对B群菌株NZ 98/254的杀菌抗体。

主要发现

  • 所有年龄段中,2019至2021年间具有阳性滴度(≥4)的个体比例显著下降。
  • 6至24月龄婴儿2019、2020和2021年的SBA几何平均滴度(GMT)显著高于2001至2004年获得的GMT。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVES: Cases of Invasive Meningococcal Disease (IMD) dropped sharply due to non-pharmaceutical interventions during the Covid-19 pandemic, raising the possibility of a disease rebound due to an immunity gap. This has been investigated via a seroprevalence study of individuals less than 25 years old, by measuring meningococcal serogroup B (MenB) serum bactericidal antibody (SBA) titres in sera collected during 2019, 2020 and 2021. SBA titres in vaccine-eligible populations since the introduction of 4CMenB were also evaluated via comparison with data obtained before vaccine introduction. METHODS: Serum samples were obtained from the United Kingdom Health Security Agency (UKHSA) Seroepidemiology Unit (SEU) and stratified by age. 1656 samples were requested of which 1586 samples were available. Functional antibody levels were analysed using a standardised, validated SBA assay against serogroup B strain NZ 98/254 (B: P1.7-2,4: ST-42 (cc41/44)). Samples were excluded if they were insufficient, did not obtain a titre or showed evidence of non-complement mediated lysis. RESULTS: 1371 valid titres were obtained. There was a significant decrease in the proportion of individuals (all ages) with a positive titre (≥4) between 2019 and 2021. For 2019, 2020 and 2021, SBA geometric mean titres (GMTs) in infants aged 6 to 24 months were significantly higher than GMTs obtained between 2001 and 2004. CONCLUSIONS: Disruption caused by the Covid-19 pandemic has resulted in a significant decrease in antibody levels, most likely due to reduced exposure to circulating meningococci being carried asymptomatically in the nasopharynx. Disruption to the routine immunisation schedule is unlikely to be a contributory factor as vaccine coverage was not significantly affected during the epidemiological year 2020 to 2021. Routine immunisation of infants has resulted in a significant increase in SBA GMTs in infants aged 6 to 24 months, compared to an age-matched population prior to the vaccine introduction.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Louth J, Holland A, Chum C, et al. Understanding the immunity gap for serogroup B invasive meningococcal disease due to non-pharmaceutical interventions during the Covid-19 pandemic. Vaccine. 2025. PMID: 40850292. doi:10.1016/j.vaccine.2025.127647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。